Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis

Background: Sjögren's Syndrome (SS) and Rheumatoid Arthritis (RA) are autoimmune conditions that often coexist in female patients. Biomarkers such as antinuclear antibodies (ANA) and rheumatoid factor (RF) are used for diagnosis, but their predictive power for treatment outcomes remains unclear...

Full description

Saved in:
Bibliographic Details
Main Authors: Anitha Krishnan Pandarathodiyil, Hema Shree K, Pratibha Ramani, B. Sivapathasundharam, Ramya Ramadoss
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Journal of Oral Biology and Craniofacial Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212426825000144
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856809149988864
author Anitha Krishnan Pandarathodiyil
Hema Shree K
Pratibha Ramani
B. Sivapathasundharam
Ramya Ramadoss
author_facet Anitha Krishnan Pandarathodiyil
Hema Shree K
Pratibha Ramani
B. Sivapathasundharam
Ramya Ramadoss
author_sort Anitha Krishnan Pandarathodiyil
collection DOAJ
description Background: Sjögren's Syndrome (SS) and Rheumatoid Arthritis (RA) are autoimmune conditions that often coexist in female patients. Biomarkers such as antinuclear antibodies (ANA) and rheumatoid factor (RF) are used for diagnosis, but their predictive power for treatment outcomes remains unclear. This study aims to investigate the correlation between age, ANA, RF, and treatment response in female patients with both SS and RA. Objective: To evaluate the relationships between age, ANA, RF levels, RA (disease present), and treatment response using Pearson correlation analysis and a neural network model, to predict treatment outcomes in patients with coexisting SS and RA. Methods: A cohort of 56 female patients aged 30–73 was analyzed. Descriptive statistics provided an overview of key variables, followed by Pearson correlation analysis to assess relationships between age, ANA, RF, RA, and treatment response. A neural network model was developed to predict treatment response based on age, ANA, and RF levels, using a training-to-testing split of 81.3 % and 18.8 %, respectively. Results: The Pearson correlation analysis revealed a significant positive correlation between age and ANA levels (r = .541, p = 0.031), though no significant correlations were found between age, RF, RA, and treatment response. The neural network model achieved an accuracy of 92.3 % during training and 100 % accuracy during testing for most treatment categories. However, the model struggled to accurately distinguish between certain classes, particularly treatment categories 1 and 3. Conclusion: Age showed a significant correlation with ANA levels, indicating that older patients may have elevated ANA. The neural network model demonstrated strong predictive power for treatment response, although further refinement is needed to improve its ability to distinguish between all response categories. These findings suggest that machine learning models could enhance personalized treatment strategies for patients with SS and RA, but additional validation with larger datasets is required.
format Article
id doaj-art-265125713d9c46babf134e5d62ae420e
institution Kabale University
issn 2212-4268
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Journal of Oral Biology and Craniofacial Research
spelling doaj-art-265125713d9c46babf134e5d62ae420e2025-02-12T05:31:01ZengElsevierJournal of Oral Biology and Craniofacial Research2212-42682025-03-01152288296Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritisAnitha Krishnan Pandarathodiyil0Hema Shree K1Pratibha Ramani2B. Sivapathasundharam3Ramya Ramadoss4Faculty of Dentistry, SEGi University, Kota Damansara, 47810 Petaling Jaya, Selangor, MalaysiaDepartment of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, Saveetha Institute Medical and Technical Science, Saveetha University, Chennai, IndiaDepartment of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, Saveetha Institute Medical and Technical Science, Saveetha University, Chennai, IndiaDepartment of Oral Pathology, Priyadarshini Dental College, Thiruvallur, Chennai, IndiaDepartment of Oral Biology, Saveetha Dental College and Hospitals, Saveetha Institute Medical and Technical Science, Saveetha University, Chennai, India; Corresponding author.Background: Sjögren's Syndrome (SS) and Rheumatoid Arthritis (RA) are autoimmune conditions that often coexist in female patients. Biomarkers such as antinuclear antibodies (ANA) and rheumatoid factor (RF) are used for diagnosis, but their predictive power for treatment outcomes remains unclear. This study aims to investigate the correlation between age, ANA, RF, and treatment response in female patients with both SS and RA. Objective: To evaluate the relationships between age, ANA, RF levels, RA (disease present), and treatment response using Pearson correlation analysis and a neural network model, to predict treatment outcomes in patients with coexisting SS and RA. Methods: A cohort of 56 female patients aged 30–73 was analyzed. Descriptive statistics provided an overview of key variables, followed by Pearson correlation analysis to assess relationships between age, ANA, RF, RA, and treatment response. A neural network model was developed to predict treatment response based on age, ANA, and RF levels, using a training-to-testing split of 81.3 % and 18.8 %, respectively. Results: The Pearson correlation analysis revealed a significant positive correlation between age and ANA levels (r = .541, p = 0.031), though no significant correlations were found between age, RF, RA, and treatment response. The neural network model achieved an accuracy of 92.3 % during training and 100 % accuracy during testing for most treatment categories. However, the model struggled to accurately distinguish between certain classes, particularly treatment categories 1 and 3. Conclusion: Age showed a significant correlation with ANA levels, indicating that older patients may have elevated ANA. The neural network model demonstrated strong predictive power for treatment response, although further refinement is needed to improve its ability to distinguish between all response categories. These findings suggest that machine learning models could enhance personalized treatment strategies for patients with SS and RA, but additional validation with larger datasets is required.http://www.sciencedirect.com/science/article/pii/S2212426825000144Sjögren's syndromeRheumatoid arthritisAntinuclear antibodiesRheumatoid factorNeural networkTreatment response
spellingShingle Anitha Krishnan Pandarathodiyil
Hema Shree K
Pratibha Ramani
B. Sivapathasundharam
Ramya Ramadoss
Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
Journal of Oral Biology and Craniofacial Research
Sjögren's syndrome
Rheumatoid arthritis
Antinuclear antibodies
Rheumatoid factor
Neural network
Treatment response
title Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
title_full Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
title_fullStr Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
title_full_unstemmed Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
title_short Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis
title_sort exploring the predictive power of antinuclear antibodies and rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting sjogren s syndrome and rheumatoid arthritis
topic Sjögren's syndrome
Rheumatoid arthritis
Antinuclear antibodies
Rheumatoid factor
Neural network
Treatment response
url http://www.sciencedirect.com/science/article/pii/S2212426825000144
work_keys_str_mv AT anithakrishnanpandarathodiyil exploringthepredictivepowerofantinuclearantibodiesandrheumatoidfactorcorrelationsinanticipatingtherapeuticoutcomesforfemalepatientswithcoexistingsjogrenssyndromeandrheumatoidarthritis
AT hemashreek exploringthepredictivepowerofantinuclearantibodiesandrheumatoidfactorcorrelationsinanticipatingtherapeuticoutcomesforfemalepatientswithcoexistingsjogrenssyndromeandrheumatoidarthritis
AT pratibharamani exploringthepredictivepowerofantinuclearantibodiesandrheumatoidfactorcorrelationsinanticipatingtherapeuticoutcomesforfemalepatientswithcoexistingsjogrenssyndromeandrheumatoidarthritis
AT bsivapathasundharam exploringthepredictivepowerofantinuclearantibodiesandrheumatoidfactorcorrelationsinanticipatingtherapeuticoutcomesforfemalepatientswithcoexistingsjogrenssyndromeandrheumatoidarthritis
AT ramyaramadoss exploringthepredictivepowerofantinuclearantibodiesandrheumatoidfactorcorrelationsinanticipatingtherapeuticoutcomesforfemalepatientswithcoexistingsjogrenssyndromeandrheumatoidarthritis